Dr. Boughey on Locoregional Trials for Breast Cancer

Video

In Partnership With:

Judy C. Boughey, MD, chair, Division of Surgery Research, Mayo Clinic, discusses locoregional clinical trials for breast cancer.

Judy C. Boughey, MD, chair, Division of Surgery Research, Mayo Clinic, discusses locoregional clinical trials for breast cancer.

Boughey stresses the importance of understanding active clinical trials and unanswered questions to advance breast cancer care. For example, a recent study examined patients with node-positive breast cancer treated with neoadjuvant chemotherapy. Medical oncologists, she adds, are becoming more effective at administering systemic therapy.

While systemic therapies and targeted therapies are improving, Boughey says that surgical oncologists are also observing less disease in the breast and lymph nodes prior to surgery. This raises the question whether or not surgical oncologists need to remain maximally invasive in these patients or if they can adjust surgical management.

Related Videos
Emmanuel Antonarakis, MD, associate director, Translational Research, Masonic Cancer Center, University of Minnesota, Clark Endowed Professor of Medicine, University of Minnesota Medical School
Gautam Jha, MD, medical director, M Health Fairview Masonic Cancer Clinic and the Advanced Treatment Center at the M Health Fairview Clinics and Surgery Center—Minneapolis, chair, cancer committee, M Health Fairview Ridges Hospital
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD